Listed

Ocean Biomedical, Inc.

OCEAOTCCIK 1869974HealthcareFiscal year ends Dec 31

Reports and events: 111 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Ocean Biomedical, Inc., Reports and events
FiledFormWhat it isAccession number
2023-06-1508:08 ETS-1/ARegistration statement, amended0001493152-23-021385
2023-06-0812:56 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001493152-23-020592
2023-06-0105:01 ETS-1/ARegistration statement, amended0001493152-23-019757
2023-05-2604:01 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-019176
2023-05-2412:26 ET10-QQuarterly reportPeriod 2023-03-310001493152-23-018924
2023-05-1604:01 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits0001493152-23-017639
2023-04-2112:44 ETS-1Registration statement0001493152-23-013239
2023-03-3113:17 ET8-K/A9.01 Financial statements and exhibits0001493152-23-010412
2023-03-3110:33 ET10-KAnnual reportPeriod 2022-12-310001493152-23-010129
2023-03-2715:04 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-008961
2023-03-2415:30 ETSC 13D/AOwnership report, active investor, amended0001493152-23-008741
2023-03-1704:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-008008
2023-02-2412:02 ETSC 13DOwnership report, active investor0001493152-23-006020
2023-02-2411:53 ETSC 13DOwnership report, active investor0001493152-23-006017
2023-02-1706:17 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-005384
2023-02-1503:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-005140
2023-02-1516:30 ET8-K/A1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 9.01 Financial statements and exhibits0001493152-23-005097
2023-02-1516:22 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 9.01 Financial statements and exhibits0001493152-23-005096
2023-02-1306:29 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-004412
2023-02-1304:14 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-004392
2023-02-1313:33 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-004349
2023-02-1009:55 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-004252
2023-02-0904:15 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-004004
2023-02-0804:34 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-003917
2023-02-0704:15 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-23-003801
2023-02-0604:15 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-003651
2023-02-0112:28 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-003332
2023-01-3004:15 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-002865
2023-01-2404:15 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-002272
2023-01-1312:10 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-001461
2023-01-1208:59 ETDEF 14AProxy statementPeriod 2023-01-120001493152-23-001281
2022-12-1603:30 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-035673
2022-12-1304:09 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-035252
2022-12-0803:01 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-22-034826
2022-11-2111:05 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-22-033099
2022-11-0407:23 ET8-K/A7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-030426
2022-11-0108:02 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-030076
2022-11-0105:15 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-030067
2022-10-1712:05 ET10-QQuarterly reportPeriod 2022-09-300001493152-22-028552
2022-10-0503:50 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-22-027656
2022-09-2203:45 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-026524
2022-09-1903:45 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-026171
2022-09-1205:20 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-025581
2022-09-0913:14 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-22-025519
2022-09-0813:30 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-025398
2022-09-0817:42 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-22-025301
2022-09-0603:45 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-025056
2022-08-3104:00 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-024442
2022-07-1912:45 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001493152-22-019839
2022-07-1112:35 ET10-QQuarterly reportPeriod 2022-06-300001493152-22-019014

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.